TNFSF13 CLIA Kit

Produktnummer ABIN6230689

Produktdetails TNFSF13 CLIA Kit

Target: TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))

Reaktivität: Maus

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.625 ng/mL - 40 ng/mL

Untere Nachweisgrenze: 0.625 ng/mL

Applikation: ELISA

Verwendungszweck: Mouse Tumor necrosis factor ligand superfamily member 13 (TNFSF13) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma and other biological fluids.

Proben: Plasma, Serum

Analytische Methode: Quantitative

Sensitivität: < 0.265 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))

Andere Bezeichnung: TNFSF13 (TNFSF13 Produkte)

Synonyme: APRIL CLIA Kit, CD256 CLIA Kit, TALL-2 CLIA Kit, TALL2 CLIA Kit, TRDL-1 CLIA Kit, ZTNF2 CLIA Kit, 2310026N09Rik CLIA Kit, April CLIA Kit, Tall2 CLIA Kit, Trdl1 CLIA Kit, SLAN CLIA Kit, ANP32B CLIA Kit, april CLIA Kit, tnf13 CLIA Kit, TNLG7B CLIA Kit, TNF superfamily member 13 CLIA Kit, tumor necrosis factor (ligand) superfamily, member 13 CLIA Kit, acidic leucine-rich nuclear phosphoprotein 32 family member B CLIA Kit, TNFSF13 CLIA Kit, Tnfsf13 CLIA Kit, LOC494442 CLIA Kit, tnfsf13 CLIA Kit

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response